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Introduction 
Micro RNAs (miRNAs) compose a large family: about 1% of the genes 
encoded in the genome belong to the miRNA family. First described in 1993 
miRNAs are short, being composed of only 18-25 nucleotides and play an 
important role in post-transcriptional regulation of gene-expression, through 
RNA interference (RNAi). The hypothesis, that miRNAs exert their regulatory 
function in networks is supported by the high number of non-coding RNAs 
which are functionally active. Emerging knowledge surrounding the role of 
miRNAs in the regulation of post-transcriptional gene expression has 
dramatically altered the view of how target genes are regulated. 
A single microRNA may alter the expression of a large number of target 
genes, thus influencing a specific pathology by regulating whole disease-specific 
pathways and signaling cascades rather than a single gene. This unique function 
underlines the immense importance of these small molecules. A functional 
investigation of selected miRNAs is ongoing and research is now trying to 
influence expression of miRNA in different disease states. Presently, 
experimental strategies aimed at interfering with miRNAome are based on 
transfection of small, pre-determined nucleic acid sequences into target cells. 
The most effective miRNA inhibitors like the antisense oligonucleotides (ASO) 
act on the mature miRNA. Chemical modification (e.g. locked nucleic acids 
(LNA)) is usually applied to stabilize the ASOs against nuclease degradation, 
improve affinity for target miRNA and to promote tissue uptake for in vivo 
delivery. 
The role of miRNAs is currently under intense investigation in many 
disease areas. Acute kidney injury (AKI) is a frequent complaint in clinical 
nephrology, thus represents a major socioeconomic health problem. Prerenal 
etiology (e.g. hypoperfusion in circulatory shock or during cardiac surgery) 
through ischemia-reperfusion (I/R) injury of the kidney is one of the primary 
causes of AKI. Moreover, it is commonly associated with the transplantation 
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procedure and thus an unavoidable phenomenon in transplanted kidneys. AKI is 
also increasingly recognized as a cause of chronic kidney disease. Currently, a 
targeted and specific therapy for this important clinical disorder is not available. 
The role of miRNAs in the I/R-induced AKI, though under intensive research is 
yet unclear. Besides their involvement in the pathological processes, several 
miRNAs were also evaluated as biomarkers in renal I/R induced AKI. The 
disease-specific miRNA alterations may provide future diagnostic tools and 
therapeutic targets for AKI. 
3 
 
Objectives 
The objective of the thesis was to gain insight and understanding into the 
involvement of miRNAs in renal ischemia-reperfusion injury. Therefore our 
aims were (Figure 1): 
1. to estimate which miRNA could be changed in renal ischemia-
reperfusion injury through a comprehensive literature investigation; 
2. to identify and validate selected miRNAs in ischemic acute kidney 
injury; 
3. to analyze the function of the validated miRNAs, by: 
a. time-course study, to investigate in which phase of AKI are the 
miRNAs upregulated; 
b. evaluating the efficiency of a miRNA based therapy. 
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Figure 1. Objectives and work-plan. 
 
Identification of the miR-17 family in a murine renal I/R injury model and 
the time-course study of several miRNAs, carried out at Semmelweis University 
resulted in an original research article (further referred to as: miR-17 study). The 
investigation of miR-24 in ischemic AKI, containing target validation and in 
vivo evaluation of a miR-24 based therapeutic strategy, was carried out at 
Hannover Medical School and lead to another research article (further referred 
to as: miR-24 study). 
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Methods 
 
Kidney ischemia-reperfusion injury 
Acute kidney injury was induced by renal ischemia-reperfusion (I/R) 
injury in male C57BL/6 mice. After anesthesia the left renal pedicle was 
prepared and clamped. Sham operated control mice were also prepared in the 
same manner as those subjected to ischemia except that the renal pedicle was 
not clamped. The durations of reperfusion varied between 1 day and 7 days, in 
function of the experiment. For the survival analysis bilateral renal I/R injury 
was performed. 
LNA-modified miRNA oligonucleotides therapies 
Mice were dosed with intraperitoneal injections (i.p.) of a locked nucleic 
acid (LNA) modified oligonucleotide targeting miR-24 (LNA-24) as well as 
control LNA (directed against a microRNA expressed in Caenorhabditis 
elegans) (LNA-CTR) at a concentration of 10 mg/kg 24 hours before the 
operation. 
Ex vivo cell purification/sorting  
The cellular origin of miR-24 following induction of I/R-injury was 
investigated by fluorescence-activated cell sorting (FACS) analysis using 
specific antibodies: anti-CD31 for endothelial cells, Lotus tetragonolobus 
agglutinin (LTA) for proximal epithelium and anti-Tim1 for injured proximal 
epithelium. PDGF-Receptor beta+ pericytes were separated from kidneys by 
MACS magnetic bead separation.  
Plasma Urea and NGAL ELISA 
Renal function was evaluated by determination of blood urea nitrogen 
(BUN) retention. Urea values were divided by 2.14 to obtain BUN levels.  
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The levels of neutrophil gelatinase associated lipocalin (NGAL), a 
sensitive marker of tubular epithelial damage was determined with ELISA. The 
NGAL concentrations were calculated using a four parameter logistic curve-fit. 
Histology and immunohistochemistry 
Renal tissue samples fixed in buffered formaldehyde were dehydrated and 
embedded in paraffin wax (FFPE) for histology and immunohistochemistry. 
Blocks of 70-sample tissue microarrays (TMA) were made from each FFPE 
kidney. Renal tubular necrosis and regeneration were evaluated in Periodic acid-
Schiff (PAS) stained TMA sections. Renal tubular cell damage was evaluated 
also by NGAL immunostaining. For inflammatory cell influx the following 
primary antibodies were used: anti-F4/80 for macrophages, anti-CD45 for 
leucocytes, anti-Ly-6G/Gr-1 for neutrophils, anti-CD4 for T helper 
lymphocytes. Capillary rarefaction in the outer medulla was evaluated with anti-
CD31 antibody. A fluorescein in situ cell death detection kit was used for 
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. 
Cell Culture experiments 
For in vitro analyses immortalized human kidney proximal tubular 
epithelial cells (HK-2) were used. Transient liposomal transfection of miRNAs 
was carried out using specific and control miRNA and Lipofectamine 2000. 
Scratch wound healing assay was also performed: after the scratches in the cell 
monolayer were generated the cells were photographed at 0, 8, and 24 hours and 
the cell free area was calculated. 
RNA preparation 
Total RNA was extracted from the upper third of the kidney with TRI-
Reagent. The RNA concentration and purity was inspected by the 260 nm / 280 
nm absorbance ratio. RNA samples were also electrophoresed on agarose gel 
and the 28S and 18S ribosomal RNA fraction integrity was examined. 
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Multiplex analysis of the microRNA profile  
The expression of 46 microRNAs was determined with the 
Luminex® 200™ System. First, the extracted RNA was poly (A) tailed and 
biotinylated and then sample RNA hybridization with the bead mix and 
microRNA detection was performed. All samples were tested in duplicates and 
the background median fluorescence intensity (MFI) was subtracted before 
further calculations. MicroRNAs with low median fluorescence intensity were 
excluded from the statistical analysis. 
Quantitative real-time PCR analysis of miRNAs and gene expression in renal 
tissue 
MicroRNA expressions were evaluated with TaqMan probes and real-
time quantitative PCR (qPCR). Gene mRNA levels were measured by dsDNA 
dye based SYBR Green qPCR. All samples were measured in duplicates and 
expressions were calculated using the relative quantification (ΔΔCq) method. 
The qPCR reaction efficiency was also verified with standard curves. Gene array 
analysis was performed with Affymetrix GeneChip. 
MicroRNA target prediction  
MicroRNA databases and in silico target prediction tools were used to 
identify potential microRNA targets. Targets predicted by at least two prediction 
data bases and containing a miR-24-8mer seed match in the respective 3’UTR 
region were considered. 
Statistical analysis 
Continuous variables were compared using unpaired T-test or one-way 
analysis of variance (ANOVA), followed by the Dunnett's multiple comparison 
post hoc test versus the (sham) control group or Tukey's multiple comparisons 
test. Linear correlation was assessed with Pearson product-moment correlation 
coefficient. The null-hypothesis was rejected if the two-sided p-value reached 
statistical significance (* = p<0.05, ** = p<0.01, *** = p<0.001). 
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Results 
miR-17 study 
Lethal renal ischemia-reperfusion injury markers 
After lethal, 30 min I/R injury the main histological lesions were found in 
the outer stripe of the outer medulla, and to a lesser degree in the cortical region. 
Immunohistochemistry of the renal tubular damage marker NGAL demonstrated 
a strong NGAL specific tubular staining after I/R injury in the outer stripe and 
cortex. Whole kidney NGAL mRNA, plasma NGAL and BUN level increased 
compared to the sham operated group. 
Kinetics of sublethal renal ischemia-reperfusion injury markers 
Twenty-four hours after 20 min ischemia all kidney damage markers 
increased significantly. Thereafter, histologic signs of tubular regeneration 
appeared and renal damage markers started to decrease. On the fourth day of 
reperfusion all damage markers returned close to sham values. 
Micro RNA expression changes and time-course of renal miR-17-5p, miR-
106a and miR-21 expressions after renal ischemia-reperfusion injury 
Five (miR-21, miR-17-5p, miR-106a, let-7c and miR-99a) miRNAs had a 
significantly different expression relative to the sham operated group (Figure 2). 
However, only miR-21, miR-17-5p, and miR-106a changed more than 30% after 
I/R injury. The qPCR analysis confirmed the significance of the results 
regarding miR-17, miR-21 and miR-106a. After sublethal ischemia miR-17-5p 
increased significantly after one day of reperfusion, and remained significantly 
elevated until the third day. On the other hand, renal miR-21 expression was 
first elevated after three days of reperfusion, and remained upregulated on the 
fourth day, when miR-17-5p expression already returned to the sham-operated 
level. 
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Figure 2. The miRNA expression profile of renal I/R injury, measured on the 
Luminex multiplex platform (fold changes observed after 24 hours of 
reperfusion following 30 min ischemia, compared to the sham-operated group). 
Correlation between renal miR-17-5p and miR-21 expressions 
Significant correlations were detected between renal miR-17-5p and miR-
21 expressions at every studied time point in both the ischemia-reperfusion and 
sham-operated groups. However, the slopes of the regression lines were 
significantly different between the ischemia-reperfusion and sham-operated 
groups on the third and fourth days of reperfusion. Moreover, the slopes became 
steeper as the reperfusion time increased. 
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miR-24 study 
miR-24 in renal I/R-injury 
Levels of miR-24 were increased in mouse kidneys at 1 and 7 days after 
induction of I/R injury compared to contralateral control kidneys. Cell sorting 
analysis after I/R-injury revealed a specific enrichment of miR-24 in tubular 
epithelial and endothelial cells at 1 day of reperfusion. At a reperfusion time of 7 
days after I/R-injury miR-24 was up-regulated in injured tubular epithelial cells, 
although in healthy tubules changed to levels of controls. A slight, non-
significant decrease in miR-24 expression was detected in pericytes. In kidney 
transplant biopsies of patients with prolonged cold ischemia time an increase in 
miR-24 was detected. 
Functional role of miR-24 in tubular epithelial cells 
Intriguingly, transfection of cells with miR-24 precursors without any 
additional cellular stressors culminated in an increase in apoptosis as assessed 
by TUNEL staining. Scratch migration analysis following miR-24 enrichment 
indicated a defect in tubular epithelial migratory capacity. 
Targets of miR-24 in vitro 
After a global messenger RNA expression analysis in proximal tubular 
epithelial cells following overexpression of miR-24 precursors 1822 genes were 
down-regulated compared to cells transfected with a pre-negative control 
oligonucleotide. In our subsequent analyses we focused on sphingosine-1-
phosphate receptor 1 (S1PR1), H2A histone family, member X (H2A.X) and 
Heme Oxygenase-1 (HO-1). 
Markers of kidney damage and endothelial activation in I/R-injury after miR-
24 silencing 
Treatment of mice with an LNA-modified antimiR targeting miR-24 
(LNA-24) before unilateral I/R injury not only resulted in a better survival, but 
also in a marked reduction of kidney injury marker (NGAL and KIM-1) gene 
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expression and amelioration of renal function parameters (serum-creatinine and 
-urea). Epithelial cell injury and capillary rarefaction on day 1 after I/R-injury 
was significantly improved in animals treated with an LNA-modified antimiR 
targeting miR-24. 
Kidney morphology, infiltration of immune cells, level of apoptosis after miR-
24 silencing 
LNA-24 treatment resulted in a significant improvement of kidney 
morphology on day 1 after I/R-injury. Infiltration of leucocytes, macrophages, 
T-cells, and neutrophils significantly decreased following LNA-24 treatment at 
all investigated time points. Tubular cell apoptosis was significantly lower in 
LNA-24 treated animals at 1 day of reperfusion. 
Target regulation of miR-24 in I/R-injury in vivo 
We found HO-1 to be significantly up-regulated in the outer medulla after 
anti-miR-24 LNA as compared to control LNA (LNA-CTR) treated animals. 
H2A.X was also found to be up-regulated by miR-24 inhibition, though not to a 
statistically significant level. S1PR1 was not regulated in vivo. 
MiR-24 in the progression from acute kidney injury to chronic kidney disease 
At a reperfusion time of 7 days the level of developing fibrosis and 
expression of fibrosis-associated genes was highly reduced in LNA-24 treated 
mice subjected to unilateral I/R-injury (Figure 3). 
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Figure 3. Fibrosis development (sirius red-staining) analysis in mice with renal 
I/R injury treated with control LNA (LNA-CTR) and LNA-24 and quantification 
of results at reperfusion for 7 days. 
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Conclusions 
The presented results demonstrated that miR-17-5p, miR-21, miR-106a 
and miR-24 are involved in the pathophysiologic processes of the ischemia-
reperfusion (I/R)-induced acute kidney injury (AKI). 
The miR-17 study showed that miR-17 upregulation occurred during the 
maintenance phase and was followed later by miR-21 upregulation, which in 
turn lasted until the recovery phase. The expression of these miRNAs correlated 
with each other, which finding should be further investigated to get a deeper 
understanding of a possible relationship between miR-21 and miR-17. The 
timing of miRNA up-regulations suggests that miR-17 and miR-21 could play a 
role in the recovery phase of the I/R-induced AKI. Considering the progresses 
made in miRNA research in the kidney and miRNA based therapeutic 
approaches miR-17-5p, miR-21 and miR-106a could represent novel targets in 
the treatment of the ischemia-induced AKI. 
The miR-24 study revealed that miR-24 contributes to renal I/R-injury by 
influencing tubular epithelial and endothelial apoptosis through regulation of 
anti-apoptotic HO-1 and H2A.X. Here we provide clear evidence of the pro-
apoptotic role of miR-24 in renal I/R-injury. Silencing miR-24 ameliorates the 
apoptotic response in vivo leading to suppressed tubular epithelial and 
endothelial apoptosis, which is associated in turn with enhanced capillary 
density and reduced tubulo-interstitial fibrosis and the potential of blunting the 
AKI (acute kidney injury) to CKD (chronic kidney disease) continuum. Of note, 
this is the first evidence demonstrating that pharmacological miRNA inhibition 
might be a viable therapeutic option in the treatment of patients with this life-
threatening clinical disorder. Intriguingly, miR-24 is also enriched in transplant 
kidneys of patients with prolonged cold ischemia time, indicating its potential 
role in human renal I/R- injury. This study highlights that miR-24 modulation 
might ultimately lead to the first targeted clinically applicable therapy of 
patients with AKI. 
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